NCT02650830 Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative Stress Status COMPLETED Phase N/A
NCT02639988 Impact of Rheumatoid Arthritis on the Course of Type 2 Diabetes During a Longitudinal Follow-up of 5 Years Status TERMINATED Phase N/A
NCT02637973 Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02633722 Intermittent Fasting for Metabolic Health, Does Meal Timing Matter? Status COMPLETED Phase NA
NCT02628301 Microvascular Dysfunction and the Development of Whole-body Insulin Resistance Status COMPLETED Phase NA
NCT02611596 Does Ranolazine Decrease Biomarkers of Myocardial Damage in Diabetics Status WITHDRAWN Phase NA
NCT02608177 Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management Status COMPLETED Phase NA
NCT02606617 A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT02598791 GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake Status COMPLETED Phase NA
NCT02588859 Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus Patients Status COMPLETED Phase N/A
NCT02583919 Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT02583438 Evaluate the Effect of Saxagliptin on Gut Microbiota in Patients With Newly Diagnosed Type 2 Diabetes Status UNKNOWN Phase PHASE4
NCT02575599 Web-based Guided Self-Determination Intervention for Adults With Type 2 Diabetes in General Practice Status UNKNOWN Phase NA
NCT02565706 Online WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption Status COMPLETED Phase NA
NCT02562573 Study to Evaluate the Safety and Tolerability of PBI-4050 in Type 2 Diabetes Patients With Metabolic Syndrome Status COMPLETED Phase PHASE2
NCT02558270 Effects of SGLT-2 Inhibition on Hepatic Glucose and Energy Metabolism Status UNKNOWN Phase PHASE2